Simulations Plus Investors
Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).
Last Funding Type:
Grant
Funding Status:
IPO
Headquarters:
United States
Founded Date:
1996-01-01
Last Funding Date:
2022-03-29
Total Funding:
1700000.0
Technology:
Biotechnology, Computer, Data Mining, Enterprise Software, Information Technology, Life Science
Employee Number:
51-100
Acquisitions Number:
4
Estimated Revenue:
$10M to $50M
Investors Number:
2.0
Industry:
Early Drug Development